Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending August 20, 2021

Overall drug TRx are +1.1% w/w

Vascepa
TRx 79,708; -2.1% (-1,673) w/w; -10.0% y/y
NRx 34,900; -2.6% (-944) w/w; -15.4% y/y
Ref 44,809; -1.6% (-728) w/w; -5.3% y/y

Lovaza (Generic & Brand)
TRx 61,922; -1.0% (-597) w/w; -0.0% y/y
NRx 29,984; -0.2% (-68) w/w; -2.4% y/y
Ref 31,938; -1.6% (-529) w/w; +2.4% y/y

Generic Vascepa
TRx 16,540; +2.7% (+432) w/w; As % of total V: 17.2%
NRx 9,089; +0.4% (+33) w/w; As % of total V: 20.7%
Ref 7,451; +5.7% (+399) w/w; As % of total V: 14.3%

Generic Vascepa by Manufacturer
Hikma TRx 12,019 (-44); Generic share 72.7%; Total V share 12.5%
Reddy TRx 4,521 (+476); Generic share 27.3%; Total V share 4.7%